TP53 and endometrioid adenocarcinoma: A patient originally diagnosed with uterine endometrioid adenocarcinoma had additional clinically relevant PIK3CA and TP53 mutations that further characterize this patient as having pleomorphic rhabdomyosarcoma (Pinto et al., 2018).